A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson’s disease.

Source: Promising respiratory drug focus of new clinical trial for parkinson's disease


David Cottle

UBB Owner & Administrator